Primary Care Reports – November 1, 2008

November 1, 2008

• Pharmacology Watch

  Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.

  Read more about Pharmacology Watch

• Clinical Briefs in Primary Care Supplement

  Read more about Clinical Briefs in Primary Care Supplement - Primary Care Reports – November 1, 2008